InteRNA Technologies and Dana-Farber Cancer Institute to Collaborate on the Role of microRNAs in Cancer Pathways
2nd November 2009 UTRECHT, The Netherlands, November 2 /PRNewswire/ -- InteRNA Technologies B.V. and the Dana-Farber Cancer Institute
(Boston, USA) have entered into a research agreement to develop microRNA...
London Genetics Focuses on Partnering Following Successful Pharmacogenetics Conference
30th October 2009 LONDON, October 30 /PRNewswire/ -- London Genetics Limited, an expert in the use of
pharmacogenetics in clinical drug discovery and development, has entered an
intensive partnering programme...
Clinical Genomics Continues Collaborative Research With CSIRO
7th October 2009 SYDNEY, October 7 /PRNewswire/ -- Sydney-based Clinical Genomics Pty Ltd and CSIRO have entered into a new
phase in their collaboration to develop improved diagnostics for cancers of
the colon and...
CSC and Cordys Establish Strategic Global Partnership
6th October 2009 PUTTEN, The Netherlands, and FALLS CHURCH, Virginia, October 6 /PRNewswire/ -- CSC (NYSE: CSC), a global leader in technology-enabled solutions and
services, and Cordys, a leading provider of...
Children's Hospital in Colorado Rounds off List of 24 Cord Blood Transplant Centers Worldwide Enrolling for ExCell Trial Studying StemEx(R) for Leukemia and Lymphoma
16th September 2009 DENVER, Colorado and JERUSALEM, September 16 /PRNewswire/ -- Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture
announced today that Children's Hospital is enrolling patients for...
Helsinn Partners With Eisai for Gelclair in Italy
15th September 2009 LUGANO, Switzerland, September 15 /PRNewswire/ -- The Swiss pharmaceutical group Helsinn and Eisai Italy,
subsidiary of the Japanese pharmaceutical company, have signed a licensing
agreement for the...
Pieris AG Enters into Anticalin Collaboration With Allergan, Inc.
15th September 2009 FREISING-WEIHENSTEPHAN, Germany, September 15 /PRNewswire/ -- Pieris AG today announced that they have entered into a collaboration
agreement with Allergan, Inc. (NYSE: AGN) that combines Pieris'...
Tosho's Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership
12th September 2009 BOZEN, Sud-Tyrol, Italy, September 12 /PRNewswire/ -- Health Robotics today announced that after a successful first year of
cooperation in Japan with Tosho Inc., the companies signed this week...
Tosho's Satisfaction With Health Robotics Steers the Japanese Pharmacy Automation Leader to Renew and to Expand its I.V. Automation Strategic Partnership
7th September 2009 BOZEN, Italy, September 7 /PRNewswire/ -- Health Robotics today announced that after a successful first year of
cooperation in Japan with Tosho Inc., the companies signed this week a
contract renewal...
Nucletron Increases Full Year Outlook After Strong First Half 2009
3rd September 2009 VEENENDAAL, the Netherlands, September 3 /PRNewswire/ -- Nucletron, a global leader in radiation oncology, today announced strong
financial results over the first half year of 2009. Despite...
SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
1st September 2009 AMSTERDAM, September 1 /PRNewswire/ -- SynCo Bio Partners B.V., the expert in long term GMP contract
manufacturing of biopharmaceuticals announced today that it has expanded its
business into a new...
Team Garmin-Slipstream Announces POM Wonderful Sponsorship
31st August 2009 LOS ANGELES, August 31 /PRNewswire/ -- POM Wonderful, the largest U.S. grower of Wonderful variety pomegranates
and maker of 100% pomegranate juice, today announced its sponsorship of...
Nuevolution Announces New Research Collaboration With Big Pharma
31st August 2009 COPENHAGEN, August 31 /PRNewswire/ -- Nuevolution A/S today announced that it has entered into a drug discovery
collaboration with Novartis.
During the collaboration, Nuevolution will apply...
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
30th August 2009 PARIS, and PRINCETON, New Jersey, August 30 /PRNewswire/ -- -No added benefit on the composite primary end-point with the higher
dose when entire ACS study population considered-
-Important new...
Cardea Technology Inc and Optasia Medical Ltd Announce Plans to Collaborate to Optimize Their Vertebral Fracture Assessment Tools
27th August 2009 BOSTON, Massachusetts and CHEADLE, England, August 27 /PRNewswire/ -- Cardea Technology, Inc. and Optasia Medical Ltd., announce plans to
collaborate and configure their software tools for Vertebral...
Shire Builds Competitive Position of its HGT Business through Research Collaboration with Santaris Pharma A/S on LNA Drug Platform
24th August 2009 CAMBRIDGE, Massachusetts, August 24 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces today that it has entered into a
research-based...
Nanosyn, Inc. and PCAS Announce the Signing of a Joint-Venture Agreement to Operate PCAS-NANOSYN, LLC
12th August 2009 LONGJUMEAU, PARIS and MENLO PARK, California, August 12 /PRNewswire/ -- PCAS, a worldwide leader in commercial scale pharmaceutical synthesis and
fine and specialty chemical manufacturing, and...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
